Search research articles
Contact Us
Filters
Showing results (41-50 of 292) with videos related to
Page
of 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 1995
Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642)
M E Costanza, D Berry, I C Henderson, et al.
Journal of the National Cancer Institute
|
February 14, 1998
Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination
B D Duggan, M Wan, M C Yu, et al.
Medical Physics
|
March 17, 1999
Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group no. 60. American Association of Physicists in Medicine
R Nath, H Amols, C Coffey, et al.
Leukemia & Lymphoma
|
July 24, 2009
Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691
S M Smith, J Johnson, B D Cheson, et al.
Blood
|
April 15, 1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811
R A Larson, R K Dodge, C P Burns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients
C L Shapiro, L Ayash, I J Webb, et al.
Human Molecular Genetics
|
November 1, 1996
Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy
E M McNally, D Duggan, J R Gorospe, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 9, 2014
Genetic analysis reveals that amyloid precursor protein and death receptor 6 function in the same pathway to control axonal pruning independent of β-secretase
Olav Olsen, Dara Y Kallop, Todd McLaughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2004
Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy
Mory Nouriani, Afshin Bahador, Jonathan S Berek, et al.
The New England Journal of Medicine
|
February 24, 2001
Gene-expression profiles in hereditary breast cancer
I Hedenfalk, D Duggan, Y Chen, et al.
Page
of 30
Search research articles
Search
Showing results (41-50 of 292) with videos related to
Sort By:
Page
of 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 1995
Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642)
M E Costanza, D Berry, I C Henderson, et al.
Journal of the National Cancer Institute
|
February 14, 1998
Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination
B D Duggan, M Wan, M C Yu, et al.
Medical Physics
|
March 17, 1999
Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group no. 60. American Association of Physicists in Medicine
R Nath, H Amols, C Coffey, et al.
Leukemia & Lymphoma
|
July 24, 2009
Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691
S M Smith, J Johnson, B D Cheson, et al.
Blood
|
April 15, 1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811
R A Larson, R K Dodge, C P Burns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients
C L Shapiro, L Ayash, I J Webb, et al.
Human Molecular Genetics
|
November 1, 1996
Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy
E M McNally, D Duggan, J R Gorospe, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 9, 2014
Genetic analysis reveals that amyloid precursor protein and death receptor 6 function in the same pathway to control axonal pruning independent of β-secretase
Olav Olsen, Dara Y Kallop, Todd McLaughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2004
Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy
Mory Nouriani, Afshin Bahador, Jonathan S Berek, et al.
The New England Journal of Medicine
|
February 24, 2001
Gene-expression profiles in hereditary breast cancer
I Hedenfalk, D Duggan, Y Chen, et al.
Page
of 30